Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,265 | 60,220 | 60,360 | 58,507 | 49,588 |
| Receivables | 120,565 | 125,245 | 108,384 | 103,407 | 106,684 |
| Inventories | 106,182 | 99,878 | 98,804 | 96,273 | 91,551 |
| Income taxes - deferred | 24,033 | 24,893 | 23,606 | 24,303 | 22,852 |
| Other current assets | 13,019 | 12,130 | 14,509 | 11,259 | 11,793 |
| TOTAL | $339,064 | $322,366 | $305,663 | $293,749 | $282,468 |
| Non-Current Assets | |||||
| PPE Net | 166,604 | 151,094 | 141,852 | 126,865 | 117,806 |
| Intangibles | 0 | 0 | 236,414 | 0 | 0 |
| Other Non-Current Assets | 259,221 | 263,397 | 18,250 | 253,619 | 245,895 |
| TOTAL | $425,825 | $414,491 | $396,516 | $380,484 | $363,701 |
| Total Assets | $764,889 | $736,857 | $702,179 | $674,233 | $646,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 742 | 731 | 720 | 710 | 699 |
| Accounts payable and accrued liabilities | 25,357 | 25,301 | 32,510 | 21,786 | 28,366 |
| Accrued Expenses | 91,199 | 76,853 | 89,042 | 90,401 | 81,777 |
| TOTAL | $299,052 | $265,026 | $223,392 | $209,170 | $213,569 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,350 | 5,540 | 5,727 | 5,911 | 6,092 |
| Deferred Revenues | 11,014 | 10,743 | 10,678 | 10,044 | 8,491 |
| Other Non-Current Liabilities | 13,939 | 13,984 | 13,830 | 17,363 | 18,261 |
| TOTAL | $37,376 | $38,195 | $40,464 | $44,923 | $48,048 |
| Total Liabilities | $336,428 | $303,221 | $263,856 | $254,093 | $261,617 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,873 | 120,601 | 121,909 | 122,454 | 122,368 |
| Common Shares | 9,502 | 9,487 | 9,450 | 4,716 | 4,700 |
| Retained earnings | 652,777 | 613,413 | 585,862 | 560,334 | 534,539 |
| Other shareholders' equity | 33,232 | 33,567 | 25,238 | 20,824 | 14,866 |
| TOTAL | $428,461 | $433,636 | $438,323 | $420,140 | $384,552 |
| Total Liabilities And Equity | $764,889 | $736,857 | $702,179 | $674,233 | $646,169 |